1. Home
  2. SDST vs BLUE Comparison

SDST vs BLUE Comparison

Compare SDST & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDST
  • BLUE
  • Stock Information
  • Founded
  • SDST 2022
  • BLUE 1992
  • Country
  • SDST United States
  • BLUE United States
  • Employees
  • SDST N/A
  • BLUE N/A
  • Industry
  • SDST Blank Checks
  • BLUE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SDST Finance
  • BLUE Health Care
  • Exchange
  • SDST Nasdaq
  • BLUE Nasdaq
  • Market Cap
  • SDST 33.1M
  • BLUE 36.9M
  • IPO Year
  • SDST N/A
  • BLUE 2013
  • Fundamental
  • Price
  • SDST $0.62
  • BLUE $4.97
  • Analyst Decision
  • SDST Buy
  • BLUE Hold
  • Analyst Count
  • SDST 2
  • BLUE 7
  • Target Price
  • SDST $1.70
  • BLUE $44.60
  • AVG Volume (30 Days)
  • SDST 959.2K
  • BLUE 1.1M
  • Earning Date
  • SDST 05-14-2025
  • BLUE 05-14-2025
  • Dividend Yield
  • SDST N/A
  • BLUE N/A
  • EPS Growth
  • SDST N/A
  • BLUE N/A
  • EPS
  • SDST N/A
  • BLUE N/A
  • Revenue
  • SDST N/A
  • BLUE $103,946,000.00
  • Revenue This Year
  • SDST $4,114.37
  • BLUE $205.45
  • Revenue Next Year
  • SDST N/A
  • BLUE $3.74
  • P/E Ratio
  • SDST N/A
  • BLUE N/A
  • Revenue Growth
  • SDST N/A
  • BLUE 127.51
  • 52 Week Low
  • SDST $0.41
  • BLUE $3.20
  • 52 Week High
  • SDST $28.38
  • BLUE $28.60
  • Technical
  • Relative Strength Index (RSI)
  • SDST N/A
  • BLUE 62.82
  • Support Level
  • SDST N/A
  • BLUE $4.40
  • Resistance Level
  • SDST N/A
  • BLUE $5.01
  • Average True Range (ATR)
  • SDST 0.00
  • BLUE 0.11
  • MACD
  • SDST 0.00
  • BLUE 0.06
  • Stochastic Oscillator
  • SDST 0.00
  • BLUE 96.72

About SDST Stardust Power Inc. Common Stock

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About BLUE bluebird bio Inc.

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

Share on Social Networks: